Project title: Modernization and renovation of instrumentation of the Comprehensive Cardiovascular Center of the General Teaching Hospital in Prague

Project start date: 15. 6. 2010
Project completion date: 31. 8. 2012
Project Budget: CZK 75,127,000
Project implementer: General University Hospital in Prague

Project brief:

This year, the General University Hospital in Prague received within the 5th call of the Integrated Operational Program, Intervention area 3.2 - Public Health Services, Supported Activities - 3.2a Controlled Modernization and Renewal of Instrumentation (Medical Devices) of National Networks of Medical Facilities, including Technical Facilities , more than 54 million crowns for the implementation of the project "Modernization and renewal of instrumentation of the Comprehensive Cardiovascular Center of the General Teaching Hospital in Prague", reg. no. CZ.1.06 / 3.2.01 / 05.06553. The project is co-financed by the European Union from the European Regional Development Fund, from the budget of the Ministry of Health of the Czech Republic. The total budget of the project exceeds CZK 75 million and the General University Hospital in Prague will pay over CZK 21 million from its own resources.

The Comprehensive Cardiovascular Center of the General Teaching Hospital in Prague is a superspecialized workplace providing care for patients with cardiovascular disease and the main objective of the project is to ensure the availability and quality of standardized health care for patients suffering from diseases such as atherosclerosis and diabetes mellitus through modernization and renewal of the center's equipment. . These diseases have a decisive impact on the health and life expectancy of the population. Any improvement will have a great social benefit. With the purchase of Angio CT and Angiographic Line, which will be purchased from the project funding, a 100% standard of equipment for the dedicated workplace will be achieved.

The project will enable to reach the maximum possible level of diagnostics and therapy, increase the possibilities of research in cardiovascular diseases and contribute to the reduction of morbidity and mortality and increase the quality of life of the population. The acquisition of new devices will clearly improve the complex care of patients with cardiovascular disease.

This project is co-financed by the European Union from the European Regional Development Fund.